Moveltipril calcium

Anti-RCN1 reticulocalbin 1, EF-hand calcium binding domain,

Anti-RCN2 reticulocalbin 2, EF-hand calcium binding domain,

Anti-RCN2 reticulocalbin 2, EF-hand calcium binding domain,

Anti-RCN2 reticulocalbin 2, EF-hand calcium binding domain,

Anti-RCN2 reticulocalbin 2, EF-hand calcium binding domain,

General description This gene encodes a carcinoma-associated antigen and is a member of a family that includes at least two type I membrane proteins. This antigen is expressed on most normal epithelial cells and gastrointestinal carcinomas and

Tourniquet, Dr. Koyle, 1/pk, 10 pk/cs

Calcium module for half-cell

A PPAR&gamma agonist that is 4-fold more potent than rosiglitazone at the PPAR&gamma receptor demonstrating an EC50 value of 0.05 &microM shows high selectivity for PPAR&gamma over PPAR&alpha (EC50 = 3.

cOmplete, Mini Protease Inhibitor Tablets, inhibit a broad spectrum of serine, cysteine, and metalloproteases, as well as calpains. Due to the optimized composition of the tablets, they show excellent inhibition effects, and are well suited for the

Inhibits ryanodine binding to ryanodine/Ca 2+ receptor channel in skeletal muscle in a dose- and time-dependent manner and increases the Ca 2+ permeability of SR vesicles. Useful for specific inactivation of nucleases during isolation of undegraded

Inhibits ryanodine binding to ryanodine/Ca 2+ receptor channel in skeletal muscle in a dose- and time-dependent manner and increases the Ca 2+ permeability of SR vesicles. Useful for specific inactivation of nucleases during isolation of undegraded